HEALTH-OBESITY/USA

A combination image displays the injection pen of Zepbound, which is a weight loss drug developed by Eli Lilly. Alongside this, the image features boxes of Wegovy, a similar medication produced by Novo Nordisk. Both products represent significant pharmaceutical developments in the treatment of obesity within the USA. These two medications, Zepbound and Wegovy, are highlighted together to showcase the current options available for patients seeking medical assistance for weight loss management.